These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12579988)

  • 1. Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience.
    Uherova P; Valdez R; Ross CW; Schnitzer B; Finn WG
    Am J Clin Pathol; 2003 Feb; 119(2):192-8. PubMed ID: 12579988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
    Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
    Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
    Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
    Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular hodgkin lymphoma: a histopathologic study.
    Kansal R; Singleton TP; Ross CW; Finn WG; Padmore RF; Schnitzer B
    Am J Clin Pathol; 2002 Jan; 117(1):29-35. PubMed ID: 11789727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
    Drakos E; Rassidakis GZ; Leventaki V; Cotta CV; Vega F; Medeiros LJ
    Am J Surg Pathol; 2009 Nov; 33(11):1725-31. PubMed ID: 19730363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
    Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
    Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
    Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
    Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component.
    Yang DT; Dunphy CH; Tripp SR; Lagoo AS; Perkins SL
    Am J Hematol; 2008 Mar; 83(3):218-21. PubMed ID: 17918256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
    Prakash S; Fountaine T; Raffeld M; Jaffe ES; Pittaluga S
    Am J Surg Pathol; 2006 May; 30(5):585-92. PubMed ID: 16699312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular lymphocyte-predominant Hodgkin lymphoma: cytopathologic correlates on fine-needle aspiration.
    Subhawong AP; Ali SZ; Tatsas AD
    Cancer Cytopathol; 2012 Aug; 120(4):254-60. PubMed ID: 22367911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
    Atayar C; Poppema S; Visser L; van den Berg A
    J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological variety of floral variant of follicular lymphoma.
    Kojima M; Yamanaka S; Yoshida T; Shimizu K; Murayama K; Ohno Y; Itoh H; Motoori T; Masawa N; Nakamura S
    APMIS; 2006 Sep; 114(9):626-32. PubMed ID: 16948815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
    Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
    Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
    Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
    Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
    Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
    Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.